Events7th International Electronic Conference on Medicinal Chemistry
Published
This submission belongs to the session S5. Round table on natural products of the event 7th International Electronic Conference on Medicinal Chemistry
Published date
02 Nov, 2021
Academic Editor
author-avatarJean Jacques Vanden Eynde
Citation
Md. Adnan, Ki Kwang Oh, Dong Ha Cho, Microwave-assisted synchronous nanogold synthesis reinforced by kenaf seed and decoding their biocompatibility and anticancer activity, in Proceedings of 7th International Electronic Conference on Medicinal Chemistry, 1 November–30 November 2021, MDPI: Basel, Switzerland, doi: 10.3390/ECMC2021-11355
Share
Email
Facebook
Twitter
LinkedIn

Microwave-assisted synchronous nanogold synthesis reinforced by kenaf seed and decoding their biocompatibility and anticancer activity

image
image
1. Department of Pharmacy, International Islamic University Chittagong, Chittagong 4318, Bangladesh, South Korea
2. Department of Bio-Health Convergence, College of Biomedical Sciences, Kangwon National University, Chuncheon 24341, Republic of Korea
Abstract

The combination of green nanotechnology and biology may contribute to anticancer therapy. In this regard, using gold nanoparticles (GNPs) as therapeutic molecules can be a promising strategy. Herein, we proposed a novel biocompatible nanogold constructed by simply microwave-heating (MWI) Au3+ ions and kenaf seed (KS) extract (as a reducing and supporting agent) within a minute. The pathways of gold nanoparticles (KS@GNPs) synthesis were optimized by varying KS concentration (λmax 528 nm), gold salt amount (λmax 524 nm), and MWI times (λmax 522 nm). TEM displayed spherical shape and narrow size distribution (5-19.5 nm) of KS@GNPs whereas DLS recorded a Z-average size of 121.7 d.nm with a zeta potential of -33.7 mV. XRD and SAED ring patterns confirmed high crystallinity and crystalline face centred cubic structure of gold. FTIR explored OH functional group involved in Au3+ ions reduction followed by GNPs stabilization. KS@GNPs exposure to RAW 264.7 and NIH3T3 cell lines did not induce toxicity while dose-dependent overt cell toxicity and reduced cell viability (26.6%) was observed in LN-229 cells. Furthermore, the IC50 (18.79 µg/mL) treatment to the cancer cell triggered cellular damages, excessive ROS generation, and apoptosis. Overall, this research exploits a sustainable method of KS@GNPs synthesis and their anticancer therapy. Taking all those aspects into account, our synthesized KS@GNPs still require in-depth research concerning their safe use in clinical settings.

Keywords
Kenaf seed
Gold nanoparticles
Biocompatibility and Anticancer activity
Poster
1. POSTER.pdf
Elucidation of significant pathways of Korean Thistle (Cirsium japonicum var. maackii (Maxim.) Matsum.) flower against cancer through network pharmacology
Design, synthesis and biological evaluation of novel tetrahydro-β-carboline derivatives with potent anti-plasmodial activity